We are live on ! Find out more
PBYI icon

Puma Biotechnology
PBYI

137 hedge funds and large institutions have $1.69B invested in Puma Biotechnology in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $48.3M | Put options by funds: $24.4M

36% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 39

1.32% more ownership

Funds ownership: 83.44% → 84.76% (+1.3%)

0% more funds holding

Funds holding: 137 → 137 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 32

36% less capital invested

Capital invested by funds: $2.61B → $1.69B (-$928M)

Holders
137
Holders Change
–
Holders Change %
0%
% of All Funds
3.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
32
Increased
53
Reduced
39
Closed
32
Calls
$48.3M
Puts
$24.4M
Net Calls
+$23.9M
Net Calls Change
+$26.6M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$32.6M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$23.9M
3
Norges Bank
Norges Bank
Norway
+$21.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.1M
5
O
OrbiMed
New York
+$15.5M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$55.1M
2
Citadel Advisors
Citadel Advisors
Florida
-$52.8M
3
TCM
Tekla Capital Management
Massachusetts
-$19.4M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$18.6M
5
RG
Redmile Group
California
-$17.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
51
BlackRock Group
United Kingdom
$3.56M +$46.5K +654 +1%
MAA
52
Managed Account Advisors
New Jersey
$3.44M +$876K +12,320 +31%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$3.07M -$193K -2,715 -6%
CS
54
Credit Suisse
Switzerland
$2.95M +$2.19M +30,730 +221%
Bank of America
55
Bank of America
North Carolina
$2.91M -$714K -10,042 -19%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$2.8M +$7.11K +100 +0.2%
Millennium Management
57
Millennium Management
New York
$2.73M +$547K +7,690 +23%
Ameriprise
58
Ameriprise
Minnesota
$2.63M +$2.66M +37,338 +1,485%
Goldman Sachs
59
Goldman Sachs
New York
$2.49M +$2.22M +31,268 +483%
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.14M +$1.11M +15,573 +92%
Balyasny Asset Management
61
Balyasny Asset Management
Illinois
$2.12M +$2.28M +32,087 New
QBFM
62
QS Batterymarch Financial Management
New York
$1.99M +$590K +8,300 +38%
Swiss National Bank
63
Swiss National Bank
Switzerland
$1.84M +$1.98M +27,900 New
IHM
64
Iguana Healthcare Management
New York
$1.81M -$533K -7,500 -21%
DCM
65
Dupont Capital Management
Delaware
$1.72M +$1.01M +14,180 +119%
BlackRock
66
BlackRock
New York
$1.72M +$7.96K +112 +0.4%
Capital Fund Management (CFM)
67
Capital Fund Management (CFM)
France
$1.71M +$1.84M +25,936 New
MSA
68
Mason Street Advisors
Wisconsin
$1.65M – – –
SFM
69
Sphera Funds Management
Israel
$1.65M +$1.78M +25,000 New
U
70
UBS
Switzerland
$1.64M +$177K +2,494 +11%
Morgan Stanley
71
Morgan Stanley
New York
$1.54M +$433K +6,085 +35%
SIA
72
Sit Investment Associates
Minnesota
$1.52M – – –
FSA
73
Franklin Street Advisors
North Carolina
$1.52M +$55.1K +775 +3%
DAM
74
Doheny Asset Management
California
$1.49M +$1.61M +22,630 New
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$1.43M +$38.2K +537 +3%
1 2
3
4 5

PBYI Hedge Fund Activity: Q2 2014 in Review

137 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q2 2014, worth a combined $1.69B — down 36% from $2.61B a quarter earlier.

Fund positioning in PBYI was balanced in Q2 2014: 32 funds opened new positions, 32 closed out, 53 added to existing stakes and 39 trimmed.

The largest buyer was BB Biotech, adding an estimated $32.6M. The largest seller was Fidelity Investments, cutting an estimated $55.1M.

  • 137 institutional investors held Puma Biotechnology (PBYI) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $1.69B of Puma Biotechnology stock for Q2 2014, down 36% quarter-over-quarter.
  • 32 funds opened new Puma Biotechnology positions in Q2 2014 and 32 closed out, a net change of 0 holders.
  • The largest Puma Biotechnology buyer in Q2 2014 was BB Biotech, an estimated $32.6M added.
  • The largest Puma Biotechnology seller in Q2 2014 was Fidelity Investments, an estimated $55.1M sold.

Based on aggregated 13F filings for Q2 2014.